In the BioHarmony Drug Report Database
Niacin
Niaspan, Niaspan Titration Starter Pack, Wampocap (niacin) is a small molecule pharmaceutical. Niacin was first approved as Niaspan on 1982-01-01. It is used to treat hypercholesterolemia, hypertriglyceridemia, pellagra, and peripheral vascular diseases in the USA. It is known to target hydroxycarboxylic acid receptor 3, hydroxycarboxylic acid receptor 2, hydroxycarboxylic acid receptor 1, and carbonic anhydrase 2.
Trade Name
|
Niaspan, Niaspan Titration Starter Pack, Wampocap |
|---|---|
Common Name
|
niacin |
ChEMBL ID
|
CHEMBL573 |
Indication
|
hypercholesterolemia, hypertriglyceridemia, pellagra, peripheral vascular diseases |
Drug Class
|
Image (chem structure or protein)